QB3 Seminar: Tim Gardner, Riffyn.

Tim Gardner founded and leads Riffyn, a global provider of Software-as-a-Service for scientific process design and data analytics. The Oakland-based startup recently closed a $15 million Series B round. At this talk, Tim will relate his motivation for starting Riffyn and discuss challenges he and his team have faced and overcome.

Where & When

Room 212, Byers Hall, UCSF Mission Bay (1700 4th St., San Francisco)
Noon to 1:00 PM, Thursday, December 5, 2019

About the Speaker

timgardner RGB 300px.png

Timothy Gardner is the Founder and the CEO of Riffyn. He was previously Vice President of Research & Development at Amyris, where he led the engineering of yeast strain and processes technology for large-scale bio-manufacturing of renewable chemicals. Earlier, he was an Assistant Professor of Biomedical Engineering at Boston University, the Founder of Cellicon Biotechnologies, and a Programmer at ALK Associates. Tim has been recognized for his pioneering work in Synthetic Biology by Scientific American, the New Scientist, Nature, Technology Review, and the New York Times. He also served as an advisor to the European Union Scientific Committees and the Boston University Engineering Alumni Advisory Board. He holds BS in Mechanical Engineering from Princeton University and a PhD in Biomedical Engineering from Boston University.

About Riffyn

Riffyn provides cloud-based process design and data analytics to R&D organizations in biotech, pharmaceutical, food and chemical industries. Riffyn’s cloud-based Scientific Development Environment (Riffyn SDE) gives customers the power to achieve repeatable outcomes, faster discoveries, and right-first-time technology scale-up. Riffyn serves enterprise R&D customers across the US, Asia, Europe and South America, and has headquartered in Oakland, CA. For more information, visit: www.riffyn.com.